8-K
Earth Science Tech, Inc. (ETST)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 26, 2025
Commission
File No. 000-55000
EARTH
SCIENCE TECH, INC.
(Exact name of registrant as specified in its charter)
| florida | 45-4267181 |
|---|---|
| (State<br> or other jurisdiction | (I.R.S.<br> Employer |
| of<br> incorporation or organization) | Identification<br> No.) |
8950SW 74 ^th^ CT
Suite1401
Miami,FL 33156, USA
(Address of principal executive offices, zip code)
(305)724-5684
(Registrant’s telephone number, including area code)
Securities
registered pursuant to Section 12(g) of the Act:
| Title of Each Class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| Common<br> Stock $0.001 par value | ETST | Over<br> the Counter Bulletin Board |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written<br> communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item2.02 Results of Operations and Financial Condition
On June 26, 2025, Earth Science Tech, Inc., a Florida corporation (the “Company”), issued a press release announcing its financial results and condition as of and for the fiscal year ended March 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1. Additionally, a presentation summarizing the Company’s financial results for the same period is furnished herewith as Exhibit 99.2.
Exhibits 99.1 and 99.2 contain certain financial information that has not been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), including references to non-GAAP financial measures and forward-looking financial guidance. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in the data tables at the end of each exhibit. These non-GAAP financial measures are presented as supplemental information and should not be considered a substitute for, or superior to, the financial measures prepared in accordance with GAAP.
The information contained in this Item 2.02, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated by reference in such filing.
Item7.01 Regulation FD Disclosure
The information set forth in Item 2.02 above is incorporated by reference into this Item 7.01 in its entirety.
Item9.01. Financial Statements and Exhibits.
(d) Exhibits – The following exhibits are filed as part of this report:
| Exhibit No. | Description |
|---|---|
| 99.1 | Press release dated June 26, 2025 |
| 99.2 | March 31, 2025, Financials Results Presentation |
| 104 | Cover<br> Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| **** | EARTH SCIENCE TECH, INC. | |
|---|---|---|
| Dated: June 26, 2025 | By: | /s/ Giorgio R. Saumat |
| Giorgio<br> R. Saumat | ||
| **** | Its: | CEO and Chairman of the Board |
Exhibit99.1
EarthScience Tech, Inc. Reports Fiscal Year-End Results for March 31, 2025, with Revenue Exceeding $33.1 Million and Net Profit of $3.2 Million
Miami, FL, June 26, 2025, Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses, today shares its financial results for the year ended March 31, 2025.
For the fiscal year ended March 31, 2025, the Company reported the following results:
| ● | Cash:<br> $1,473,228, compared to $697,721 as of March 31, 2024—an increase of $775,507, representing a 111.15% year-over-year improvement. |
|---|---|
| ● | Total Assets: $7,066,721, compared to $3,881,336 as of March 31, 2024—an increase of $3,185,385, representing an 82.07% year-over-year<br> improvement. |
| ● | Revenue:<br> $33,117,624, compared to $11,953,635 for the year ended March 31, 2024—an increase of $21,163,989, representing a 177.05% year-over-year<br> improvement. |
| ● | Gross Profit: $24,300,136, compared to $7,828,496 for the year ended March 31, 2024—an increase of $16,471,640, representing<br> a 210.41% year-over-year improvement. |
| ● | Net Profit: $3,253,635, compared to $812,139 for the year ended March 31, 2024—an increase of $2,441,496, representing a 300.63%<br> year-over-year improvement. |
| ● | Outstanding Shares: 295,347,903 shares of common stock issued and outstanding, compared to 309,981,819 shares as of March 31, 2024—a<br> reduction of 14,633,916 shares, representing a 4.72% decrease in shares outstanding. |
AboutEarth Science Tech, Inc.
Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company’s current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC, Avenvi, LLC, Mister Meds, LLC (“Mister Meds”), and Earth Science Foundation, Inc., Las Villas Health Care, Inc., DOConsultations, LLC., and an 80% interest in MagneChef.
To learn more, please visit: www.EarthScienceTech.com
RxCompoundStore.com,LLC.
RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.
To learn more please visit: www.RxCompoundStore.com
MisterMeds,LLC.
Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.
To learn more please visit: www.mistermeds.com
PeaksCurative, LLC.
Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.
To learn more please visit: www.PeaksCurative.com
LasVillas Health Care, Inc.
Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.
To learn more please visit: https://villashealth.com
Doconsultation.com,LLC.
Doconsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.
To learn more please visit: https://doconsultations.com/
Avenvi,LLC.
Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company’s ongoing $5 million share repurchase program.
To learn more please visit: www.avenvi.com
MagneChef
MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.
To learn more please visit: https://magnechef.com/
AboutEarth Science Foundation, Inc.
Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.
SAFEHARBOR ACT: Forward-Looking Statements. Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
CompanyContact:
Giorgio R. Saumat
CEO and Chairman of the Board
(305) 724-5684
IR@earthsciencetech.com
Exhibit99.2
June 25th, 2025
Symbol:ETST
FiscalYear Ends: March 31st
BusinessSummary:
Earth Science Tech, Inc. operates as a strategic holding company, focused on value creation through the acquisition, operational optimization, and management of its operating businesses. The Company’s current operations include compounding pharmaceuticals, telemedicine and real estate development through its wholly owned subsidiaries: RxCompoundStore.com, LLC, Peaks Curative, LLC (“Peaks”), Avenvi, LLC, Mister Meds, LLC, and Earth Science Foundation, Inc. Subsequent to the reporting period, the Company acquired 100% of Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.
| Executives: | Board Of Directors: | ||||
|---|---|---|---|---|---|
| ● | Giorgio<br> R. Saumat - CEO | ● | Giorgio<br> R. Saumat - Chairman | ||
| ● | Mario<br> G. Tabraue - COO | ● | Mario<br> G. Tabraue - Director | ||
| ● | Ernesto<br> L. Flores - CFO / Treasurer | ● | Yovan<br> Sanchez - Director | ||
| ● | Christopher<br> Rose - CTO | ● | Jeff<br> P.H. Cazeau, JD - Independent Director | ||
| ● | Victoria<br> Losada - Secretary | ● | Emiliano<br> Curia, MD - Independent Director | ||
| ● | Ernesto<br> L. Flores - Director | ||||
| Audit Committee: | ● | Victoria<br> Losada - Director | |||
| ● | Jeff<br> P.H. Cazeau - Chairman | ||||
| ● | Emiliano<br> Curia, MD | ||||
| ● | Ernesto<br> L. Flores | Auditing Firm: | |||
| Stephano<br> Slack, LLC | |||||
| Compensation Committee: | 125<br> Strafford Avenue, Suite 200 | ||||
| ● | Ernesto<br> L. Flores - Chairman | Wayne,<br> Pennsylvania 19087 | |||
| ● | Victoria<br> Losada | ||||
| ● | Emiliano<br> Curia, MD | Securities Counsel: | |||
| Carl<br> P. Rano, Esq. | |||||
| Contact Information: | 2733<br> East Vista Drive | ||||
| Giorgio<br> R. Saumat | Phoenix,<br> Arizona 85032 | ||||
| CEO<br> and Chairman of the Board | |||||
| Transfer Agent: | |||||
| 8950<br> SW 74th CT | Continental<br> Stock Transfer and Trust | ||||
| Suite<br> 1401 | 1 State<br> Street, 30th Floor | ||||
| Miami,<br> FL 33156 | New<br> York, New York 10004-1561 | ||||
| (305)<br> 724-5684 | Website: | ||||
| IR@EarthScienceTech.com | http://www.EarthScienceTech.Com |
| June 25th, 2025 |
| --- |
SafeHarbor
Forward-LookingStatements. Except for historical information, the matters discussed herein may be considered “forward-looking”statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Actof 1934, as amended.
Suchstatements include declarations regarding the intent, belief or current expectations of the Company and its management, including, withoutlimitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on andreflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions,as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generallycan be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking wordssuch as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,”“intend,” “belief,” “plan,” “estimate,” “target,” “predict,”“likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,”“forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks anduncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations,including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, governmentregulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or shouldunderlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Companyassumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
| June 25th, 2025 |
| --- |
BriefHistory
Founded on April 23, 2010, the company faced major challenges, including a $4 million judgment in the CBD sector that led to receivership. In a bid to recover, it acquired two small businesses—RxCompoundStore.com (RXCS) and Peaks Curative (PEAKS)—from Mario Guillermo Tabraue, now COO, via a debt note.
To exit receivership, the company needed funding and a repayment plan. Tabraue turned to longtime friend Giorgio R. Saumat, who offered a $350,000 convertible note. However, the company struggled under its debt and was near bankruptcy by September 2022.
On September 30, after a critical conversation, Saumat agreed to step in under strict terms: full control of Series B Preferred Stock, conversion of all partner debts to equity, direct negotiations with creditors, and appointment as Chairman. Tabraue agreed, and within a week, Saumat had secured most outstanding debt and converted it into equity.
From late 2022 into 2023, Saumat and Tabraue focused on building RXCS and relaunching PEAKS. Saumat became CEO in February 2023, and by mid-year, the company saw strong growth, expanded operations, and cleared all debt by December.
In 2024, RXCS and PEAKS thrived, and on October 1, the company acquired Mister Meds and Avenvi to further boost value. Subsequent to the reporting period, in April, 2025, the Company acquired 100% of Las Villas Health Care, Inc., DOConsultations, LLC, and an 80% interest in MagneChef.
| June 25th, 2025 |
| --- |
CapitalStructure
| As of: | 12/31/2023 | 03/31/2024 | 06/30/2024 | 09/30/2024 | 12/31/2024 | 03/31/2025 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Authorized | 750,000,000 | 350,000,000 | 350,000,000 | 350,000,000 | 350,000,000 | 350,000,000 | ||||||
| Outstanding | 314,850,730 | 309,981,819 | 309,050,711 | 303,635,893 | 302,664,571 | 295,347,903 | ||||||
| Float | 31,944,230 | 37,634,230 | 38,071,051 | 36,796,263 | 36,440,296 | 36,440,296 |
Asof June 20th, 2025: O/S Shares: 294,297,607 Float: 35,390,000
| June 25th, 2025 |
| --- |
Subsidiaries
RxCompoundStore.Com, based in Miami, Florida, is a fully licensed compounding pharmacy authorized to fulfill prescriptions in the following states and territories: Arizona, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Maine, Maryland, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Utah, Wisconsin and Puerto Rico. RxCompound is actively pursuing licensure in the remaining U.S. states.
Mister Meds, acquired on October 1, 2024, is in Abilene, Texas. The pharmacy received full compounding licensure in March 2025. It operates out of a 5,000 sq. ft. facility owned by Avenvi and includes advanced sterile compounding capabilities with both positive and negative pressure environments, as well as hazardous drug handling. Mister Meds is currently applying for licensure in states not yet serviced by RxCompound.
| June 25th, 2025 |
| --- |
Peaks is a telemedicine referral platform offering asynchronous consultations for Peaks-branded compounded medications prepared at RxCompound and Mister Meds. The platform operates in states where either pharmacy is licensed. Through the development of its own healthcare provider network, MyOnlineConsultation.com, and ongoing licensure expansion for both pharmacies, Peaks aims to offer services nationwide. In addition, the company has recently expanded into the veterinary market through the acquisition of Zoolzy.com.
DOConsultation was born with a passion to modernize the availability and delivery of home therapies. DOConsultations providers tailor a medication plan around your health and wellness goals and follow up with our patients to ensure results, while our partner pharmacies conveniently ship directly to your door.
Las Villas is a brick-and-mortar healthcare facility dedicated to the Spanish speaking community. Our expert-led services include advanced sexual health treatments, and customized solutions to enhance physical performance. We combine compassionate, personalized care with clear, trustworthy education—empowering you to take control of your health with confidence.
Avenvi is a diversified real estate company engaged in development, asset management, and financing. With a growing portfolio of real estate holdings, Avenvi provides turnkey solutions from development to end-user financing. It also manages investment activities for ETST and oversees the Company’s ongoing $5 million share repurchase program.
MagneChef is a direct-to-consumer retail brand. Utilizing its patents and intellectual properties, the company aims to develop new products that can be marketed and sold online. Currently, the company has developed products for cooking. MagneChef is in the process of expanding its product line for new offerings that incorporate its intellectual property.
Earth Science
Foundation
Earth Science Foundation Inc. a 501(c)(3) nonprofit organization incorporated on February 11, 2019, is the charitable arm of ETST. ESF accepts grants and donations to assist individuals who need financial support for prescription costs at both RxCompound and Mister Meds.
| June 25th, 2025 |
| --- |
FinancialPerformance
AnnualRevenue (In Millions)
| Period ended: | 3/31/2023 | 3/31/2024 | 3/31/2025 | |||
|---|---|---|---|---|---|---|
| .04 | 11.95 | 33.11 |
| June 25th, 2025 |
| --- |
AnnualGross Profit (In Millions)
| Period ended: | 3/31/2023 | 3/31/2024 | 3/31/2025 | |||
|---|---|---|---|---|---|---|
| .02 | 7.82 | 24.3 |
| June 25th, 2025 |
| --- |
AnnualTotal Assets (In Millions)
| Period ended: | 3/31/2023 | 3/31/2024 | 3/31/2025 | |||
|---|---|---|---|---|---|---|
| 2.72 | 3.88 | 7.06 |
| June 25th, 2025 |
| --- |
AnnualStockholders’ Equity (In Millions)
| Period ended: | 3/31/2023 | 3/31/2024 | 3/31/2025 | |||
|---|---|---|---|---|---|---|
| 1.11 | 2.24 | 3.85 |
| June 25th, 2025 |
| --- |
AnnualCash (In Millions)
| Period ended: | 3/31/2023 | 3/31/2024 | 3/31/2025 | |||
|---|---|---|---|---|---|---|
| 0.035 | 0.69 | 1.47 |
| June 25th, 2025 |
| --- |
AnnualEmployee Count Across All Subsidiaries
| Period ended: | 3/31/2023 | 3/31/2024 | 03/31/2025 | |||
|---|---|---|---|---|---|---|
| 13 | 36 | 76 |
| June 25th, 2025 |
| --- |
Projections(In Millions)
| FY Ending: | 3/31/2023<br> <br>(Actual) | 3/31/2024<br> <br>(Actual) | 3/31/2025<br> <br>(Actual) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue* | 0.048 | * | 11.953 | * | 33.11 | * | |||
| Cash/Equivalents* | 0.0313 | * | 0.0316 | * | 2.17 | * | |||
| Cash(Equiv)/Share | $ | 0.000 | $ | 0.000 | $ | 0.007 | ** | ||
| EPS | $ | -0.003 | $ | .003 | $ | 0.011 | ** | ||
| P/E Ratio | 0 | 22.33 | 13.64 | ** |
*InMillions
**Basedon Current Price of $0.15 & Current O/S Count of 294,297,607 shares
| June 25th, 2025 |
| --- |
*Basedon Current O/S Count of 294,297,607 shares
| June 25th, 2025 |
| --- |
*Basedon Current Price of $0.12 & Current O/S Count of 294,297,607 shares
*Basedon Current Price of $0.12 & Current O/S Count of 294,297,607 shares
| June 25th, 2025 |
| --- |
NotableEvents
| Date | News/Disclosure |
|---|---|
| 05/06/2025 | 8-K: ETST Shares Annual Letter From The CEO |
| 04/07/2025 | 8-K: ETST Completes Acquisitions and engages new Audit Firm |
| 03/19/2025 | 8-K: ETST Extends Employment Agreement with CFO and CTO |
| 03/11/2025 | 8-K: ETST Amends Acquisition Agreement for Las Villas Healthcare, LLC and DOConsultations.Com, LLC |
| 02/14/2025 | 10-Q: ETST Files 3rd Quarter Earnings Report (Unaudited) |
| 02/04/2025 | 8-K: ETST Agrees to Acquire Las Villas Healthcare, LLC; DOConsultaions.Com, LLC and Magnefuse, LLC |
| 12/30/2024 | 8-K: ETST Expands Board of Directors to 7 Members, Creates Compensation Committee and Renegotiates Executive Compensation for CEO and COO |
| 11/14/2024 | 10-Q: ETST Files 2nd Quarter Earnings Report (Unaudited) |
| 10/07/2024 | 8-K: ETST Acquires Avenvi, LLC, Mister Meds, LLC and Zoolzy.Com |
| 07/29/2024 | 10-Q: ETST Files 1st Quarter Earnings Report (Unaudited) |
| 06/28/2024 | 10-K: ETST Files FY Ending March 31st, 2024 Annual Report (Audited) |
| 04/29/2024 | 8-K: ETST Shares Annual Letter From The CEO |
| 04/19/2024 | 8-K: ETST Hires Chief Technology Officer (CTO) |
| 03/05/2024 | 8-K: ETST Hires New Chief Financial Officer (CFO) |
| 02/21/2024 | 8-K: ETST Engages New Auditor - Assurance Dimensions |
| 02/20/2024 | 8-K: ETST Files 3rd Quarter Earnings Report (Unaudited) |
| 01/29/2024 | 8-K: ETST Board of Directors Authorizes $5 Million Share Repurchase Program |
| 01/09/2024 | 8-K: ETST Reduces Authorized Share Count |
| 11/13/2023 | 8-K: ETST Files 2nd Quarter Earnings Report (Unaudited) |
| 11/08/2023 | 8-K: ETST Expands Board of Directors to 5 Members |
| 08/09/2023 | 8-K: ETST Launches DocProtocol.Com |
| 07/27/2023 | 8-K: ETST Files 1st Quarter Earnings Report (Unaudited) |
| 06/20/2023 | 8-K: ETST Files FY Ending March 31st, 2023 Annual Report (Audited) |
| 02/10/2023 | 10-Q: ETST Files 3rd Quarter Earning Report (Unaudited) |
| 11/14/2022 | 10-Q: ETST Files 2nd Quarter Earnings Report (Unaudited) |
| 11/08/2022 | 8-K: ETST Completes Acquisition of RxCompoundStore.Com and Peaks Curative |
| 10/28/2022 | 8-K: ETST Settles Debt, Giorgio R. Saumat Acquires 100% of Series B Preferred Stock |
| 08/15/2022 | 10-Q: ETST Files 1st Quarter Earnings Report (Unaudited) |